Anthony P. Bihl III - 18 Aug 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: Interim CEO, Director
Signature: /s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol: BVS
Transactions as of: 18 Aug 2023
Net transactions value: +$165,076
Form type: 4
Filing time: 22 Aug 2023, 18:20:27 UTC
Previous filing: 20 Jun 2023
Next filing: 19 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Purchase	$55,005	+13,290	+11%	$4.14	138,290	18 Aug 2023	Direct	F1
transaction	BVS	Class A Common Stock	Purchase	$110,071	+26,595		$4.14	26,595	18 Aug 2023	By Spouse's Trust	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $3.89 to $4.405, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2	Reflects shares directly held by The Irene A. Bihl Revocable Trust of which the Reporting Person and his spouse are trustees and among the beneficiaries. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $3.89 to $4.405, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Reflects shares directly held by The Irene A. Bihl Revocable Trust of which the Reporting Person and his spouse are trustees and among the beneficiaries. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.